Morgan Stanley’s Taiwan Liposome Company, Ltd. American Depository Shares TLC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-100
Closed -$1K 6855
2019
Q3
$1K Hold
100
﹤0.01% 6596
2019
Q2
$1K Sell
100
-257,350
-100% -$1.44M ﹤0.01% 6600
2019
Q1
$1.5M Buy
257,450
+257,350
+257,350% +$1.59M ﹤0.01% 3828
2018
Q4
$1K Buy
+100
New +$594 ﹤0.01% 6547

Other funds holding TLC

Morgan Stanley's TLC Position: Q4 2019 in Review

Morgan Stanley sold out of Taiwan Liposome Company, Ltd. American Depository Shares (TLC) in Q4 2019, closing a stake of 100 shares — an estimated $1K sold.

Morgan Stanley first reported a position in TLC in Q4 2018 and held it in 4 quarters. The position peaked at $1.5M in Q1 2019. 6 funds tracked by Wall St. Rank hold TLC as of Q4 2019.

  • Morgan Stanley reported no remaining Taiwan Liposome Company, Ltd. American Depository Shares position as of Q4 2019 after selling out during the quarter.
  • Morgan Stanley sold 100 Taiwan Liposome Company, Ltd. American Depository Shares shares in Q4 2019, an estimated $1K.
  • Morgan Stanley first reported a position in Taiwan Liposome Company, Ltd. American Depository Shares in Q4 2018 and held it in 4 quarters.
  • Morgan Stanley's Taiwan Liposome Company, Ltd. American Depository Shares position peaked at $1.5M in Q1 2019.
  • 6 funds tracked by Wall St. Rank held Taiwan Liposome Company, Ltd. American Depository Shares as of Q4 2019.

Based on Morgan Stanley's 13F filing for Q4 2019, filed 14 Feb 2020.